journal article·2021-01Open access

Osseointegration Pharmacology: A Systematic Mapping Using Artificial Intelligence

Mohammed Mahri, Nicole Shen, Francisco Berrizbeitia, Rania Rodan, Ammar Daer, Matthew Faigan, Doaa Taqi, Kevin Yang Wu, Motahareh Ahmadi, Maxime Ducret, Elham Emami, Faleh Tamimi

Acta Biomaterialia· Volume 119

Abstract

Clinical performance of osseointegrated implants could be compromised by the medications taken by patients. The effect of a specific medication on osseointegration can be easily investigated using traditional systematic reviews. However, assessment of all known medications requires the use of evidence mapping methods. These methods allow assessment of complex questions, but they are very resource intensive when done manually. The objective of this study was to develop a machine learning algorithm to automatically map the literature assessing the effect of medications on osseointegration. Datasets of articles classified manually were used to train a machine-learning algorithm based on Support Vector Machines. The algorithm was then validated and used to screen 599,604 articles identified with an extremely sensitive search strategy. The algorithm included 281 relevant articles that described the effect of 31 different drugs on osseointegration. This approach achieved an accuracy of 95%, and compared to manual screening, it reduced the workload by 93%. The systematic mapping revealed that the treatment outcomes of osseointegrated medical devices could be influenced by drugs affecting homeostasis, inflammation, cell proliferation and bone remodeling. The effect of all known medications on the performance of osseointegrated medical devices can be assessed using evidence mappings executed with highly accurate machine learning algorithms.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Statistical Methods in Clinical Trials · Radiomics and Machine Learning in Medical Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Surgical approach in primary total hip arthroplasty: anatomy, technique and clinical outcomes10.1503/cjs.007214 ↗
2. Association · Dental Implants · 2015
3. Current trends in dental implants10.5125/jkaoms.2014.40.2.50 ↗
4. Survey of the American Neurotology Society on Cochlear Implantation: Part 2, Surgical and Device-Related Practice Patterns10.1097/MAO.0000000000001631 ↗
5. Osseointegration—a review10.9790/0853-1601014548 ↗
6. Pharmacological Risk Assessment for Dental Implants
7. Hemostasis: A Clinical Review of Pathophysiology, Pharmacotherapy, and Perioperative Management10.1016/j.joms.2007.06.145 ↗
8. What is an evidence map? A systematic review of published evidence maps and their definitions, methods, and products10.1186/s13643-016-0204-x ↗
9. A fresh approach to evidence synthesis10.1038/d41586-018-05472-8 ↗
10. Technology-assisted title and abstract screening for systematic reviews: a retrospective evaluation of the Abstrackr machine learning tool10.1186/s13643-018-0707-8 ↗
11. Systematic review automation technologies10.1186/2046-4053-3-74 ↗
12. Waddington · 2018 · 10
13. Machine learning algorithms for systematic review: reducing workload in a preclinical review of animal studies and reducing human screening error10.1186/s13643-019-0942-7 ↗
14. Automated screening of research studies for systematic reviews using study characteristics10.1186/s13643-018-0724-7 ↗
15. Using text mining for study identification in systematic reviews: a systematic review of current approaches10.1186/2046-4053-4-5 ↗
16. Low-calorie sweeteners and health outcomes: A demonstration of rapid evidence mapping (rEM)10.1016/j.envint.2018.11.070 ↗
17. Developing a fully automated evidence synthesis tool for identifying, assessing and collating the evidence
18. A case study of data quality in text mining clinical progress notes10.1145/2669368 ↗
19. Natural language processing: state of the art and prospects for significant progress, a workshop sponsored by the National Library of Medicine10.1016/j.jbi.2013.06.004 ↗
20. Improving the utility of MeSH® terms using the TopicalMeSH representation10.1016/j.jbi.2016.03.013 ↗
21. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation10.7326/M18-0850 ↗
22. The global evidence mapping initiative: scoping research in broad topic areas10.1186/1471-2288-11-92 ↗
23. Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST)10.1186/s12874-017-0402-9 ↗
24. Witten. The WEKA Workbench. Online Appendix for "Data Mining: Practical Machine Learning Tools and Techniques", Morgan Kaufmann
25. Witten · 2016
26. Credit scoring with a data mining approach based on support vector machines10.1016/j.eswa.2006.07.007 ↗
27. Machine learning techniques for the automation of literature reviews and systematic reviews in EFSA
28. Prioritising references for systematic reviews with RobotAnalyst: A user study10.1002/jrsm.1311 ↗
29. Medication‐related dental implant failure: Systematic review and meta‐analysis10.1111/clr.13137 ↗
30. Chapter 5: Defining the review question and developing criteria for including studies
31. SYRCLE's risk of bias tool for animal studies10.1186/1471-2288-14-43 ↗
32. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review10.1111/jebm.12141 ↗
33. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies10.1016/j.ijsu.2014.07.013 ↗
34. Arden NK Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study10.1136/bmj.d7222 ↗
35. Bisphosphonate use and the risk of undergoing total knee arthroplasty in osteoporotic patients with osteoarthritis: a nationwide cohort study in taiwan10.2106/JBJS.16.00385 ↗
36. Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort10.1002/art.38789 ↗
37. An effect comparison of teriparatide and bisphosphonate on posterior lumbar interbody fusion in patients with osteoporosis: a prospective cohort study and preliminary data10.1007/s00586-015-4342-y ↗
38. Association between oral bisphosphonate use and dental implant failure among middle-aged women10.1111/j.1600-051X.2012.01854.x ↗
39. Oral bisphosphonates: early endosseous dental implant success and crestal bone changes
40. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases10.1016/j.joms.2007.09.019 ↗
41. Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy10.1097/SCS.0000000000001535 ↗
42. Oral bisphosphonates and dental implants: a retrospective study10.1016/j.joms.2007.12.040 ↗
43. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study
44. Influence of bisphosphonates on alveolar bone loss around osseointegrated implants10.1563/AAID-JOI-D-09-00114 ↗
45. Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: preliminary results of a prospective randomized trial10.1016/j.arth.2012.08.007 ↗
46. The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty: a randomized, double-blind, controlled trial10.2106/JBJS.G.01193 ↗
47. Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial10.1186/s12891-017-1577-2 ↗
48. Immediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study10.1563/AAID-JOI-D-13-00063 ↗
49. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats10.1007/s00198-013-2288-7 ↗
50. Effects of systemic zoledronic Acid administration on osseointegration of hydroxyapatite-coated and resorbable blast material surface implants in rabbit models
51. Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits10.1902/jop.2013.130046 ↗
52. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats10.1016/j.jcms.2014.01.039 ↗
53. Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats
54. Zoledronic acid causes enhancement of bone growth into porous implants10.1302/0301-620X.87B3.14665 ↗
55. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits10.1016/j.bone.2011.10.011 ↗
56. Effects of local and systemic zoledronic acid application on titanium implant osseointegration: an experimental study conducted on two surface types10.1097/SCS.0000000000003568 ↗
57. The effect of systemically administrated zoledronic acid on the osseointegration of dental implants10.1111/j.1601-0825.2012.01948.x ↗
58. Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model10.1007/s12253-009-9156-y ↗
59. Prevention of strain‐related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate10.1002/jor.20533 ↗
60. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface10.1007/s00198-012-2258-5 ↗
61. [Inhibitory effect of zoledronate sodium on periprosthetic osteolysis induced by polyethylene particles]
62. Bone formation in a carbonate-substituted hydroxyapatite implant is inhibited by zoledronate: the importance of bioresorption to osteoconduction10.1302/0301-620X.90B12.20931 ↗
63. Effect of zoledronic acid on bone healing subsequent to mini-implant insertion10.2319/070710-384.1 ↗
64. Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs10.1016/j.joms.2010.05.062 ↗
65. The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in the rabbit maxilla10.11607/jomi.2685 ↗
66. Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model10.1016/j.joms.2009.07.066 ↗
67. The effects of zoledronic acid and dexamethasone on osseointegration of endosseous implants: histological and histomorphometrical evaluation in rats10.1111/clr.12335 ↗
68. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration10.1007/s00198-009-1125-5 ↗
69. QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis10.1007/s00198-012-1925-x ↗
70. [Dose-dependent prevention of early periprosthetic bone loss by alendronate]10.1055/s-2002-22090 ↗
71. Quantitative computed tomography assessment of bone mineral density after 2 years' oral bisphosphonate treatment in postmenopausal osteoarthritis patients who underwent total knee arthroplasty10.1177/0300060513480090 ↗
72. Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study
73. Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty. A seven-year randomised controlled trial of 26 patients10.1302/0301-620X.97B3.33643 ↗
74. A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty10.2106/JBJS.I.01714 ↗
75. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty—a 5-year follow-up of 16 patients10.1177/145749691009900108 ↗
76. Nishioka · Alendronate inhibits periprosthetic bone loss around uncemented femoral components · 2007 · 25 · 179
77. Alendronate improves screw fixation in osteoporotic bone10.2106/JBJS.F.00484 ↗
78. The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty10.2106/00004623-200311000-00009 ↗
79. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients10.1007/s00223-002-1022-9 ↗
80. Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty10.1002/jor.20748 ↗
81. Teriparatide Versus Alendronate for the Preservation of Bone Mineral Density After Total Hip Arthroplasty - A randomized Controlled Trial10.1016/j.arth.2015.07.017 ↗
82. Efficacy of Alendronate for the Prevention of Bone Loss in Calcar Region Following Total Hip Arthroplasty10.1016/j.arth.2017.02.036 ↗
83. Traumatology. Prevention of early bone loss around the prosthesis by administration of anti-osteoporotic agents and influences of collared and non-collared femoral stem prostheses on early periprosthetic bone loss10.1007/s00590-012-1034-8 ↗
84. The prognosis for dental implants placed in patients taking oral bisphosphonates
85. Characteristics of implant failures in patients with a history of oral bisphosphonate therapy10.1016/j.joms.2009.09.055 ↗
86. Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized RSA study10.1080/17453670902804968 ↗
87. Three-year changes in bone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty: a prospective, randomized study10.2106/00004623-200602000-00003 ↗
88. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices10.1902/jop.2007.060514 ↗
89. Survival of dental implants in post-menopausal bisphosphonate users10.1016/j.jpor.2010.04.002 ↗
90. Effects of the long-term administration of alendronate on the mechanical properties of the basal bone and on osseointegration10.1111/clr.12492 ↗
91. Effect of alendronate on healing of extraction sockets and healing around implants10.1111/j.1601-0825.2011.01829.x ↗
92. Effects of alendronate on the removal torque of implants in rats with induced osteoporosis
93. Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals10.1590/1678-77572016-0165 ↗
94. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone10.1563/1548-1336(2008)34[76:EOOAAO]2.0.CO;2 ↗
95. Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants10.1002/jor.20272 ↗
96. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats10.1080/000164702317281369 ↗
97. Perioperative alendronate, risedronate, calcitonin and indomethacin treatment alters femoral stem fixation and periprosthetic bone mineral density in ovariectomized rats10.1007/s00776-015-0717-5 ↗
98. Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion: an experimental study in a porcine model10.1007/s00264-009-0759-4 ↗
99. Effects of chronic stress and alendronate therapy on the osseointegration of titanium implants10.1111/cid.12046 ↗
100. Influence of alendronate administration regimen on the final outcome of implant osseointegration in an osteoporotic model